# Niagen Bioscience, Inc.: Form 8-K, filed Oct 31, 2024

- Company: [Niagen Bioscience, Inc.](/companies/nage.md) (CIK 1386570)
- Form: 8-K
- Filed: 2024-10-31
- Accepted by EDGAR: Oct 31, 2024, 16:01 ET
- Period: 2024-10-31
- Accession: 0001628280-24-044541
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1386570/000162828024044541/cdxc-20241031.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1386570/000162828024044541/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1386570/000162828024044541/cdxc-20241031.htm

Filed Oct 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-044541. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.